Sanofi-Aventis completes Symbion acquisition
This article was originally published in Scrip
Sanofi-Aventis has completed the A$560 million ($481 million) acquisition of Australia's Symbion Consumer from Primary Health Care. The move is expected to help the French company expand its nutraceuticals business in the Asia-Pacific region (Scrip Online, July 22nd, 2008). Symbion Consumer, part of Symbion Health, manufactures, markets and distributes nutraceuticals and other over-the-counter products throughout Australia and New Zealand. Sanofi-Aventis will consolidate Symbion Consumer sales from September 1st. Primary Health Care bought Symbion Health for more than A$2 billion in May.